Osteopathic Manipulative Treatment for Arrhythmia

N/A

Waitlist Available

Led By Todd Cohen, MD

Research Sponsored by New York Institute of Technology

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 month from enrollment.

Summary

This trial is testing a hands-on treatment called Osteopathic Manipulative Medicine (OMM) on patients with irregular heartbeats. The goal is to see if this treatment can reduce the number of irregular heartbeats by improving overall body function. Patients will receive either the OMM treatment or another type of evaluation to compare the results.

Eligible Conditions

Arrhythmia

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 month from enrollment.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 month from enrollment.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month from enrollment. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Decrease in Cardiac Events

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Osteopathic Manipulative TreatmentExperimental Treatment1 Intervention

Group A will receive osteopathic treatment by NMM/OMM board certified attending physicians. The protocol for the OMT intervention group is based on the guidelines set forth previously in textbooks. The protocol will last 25 minutes total, with 10 minutes for the evaluation and 15 minutes for treatment. The protocol will start in ribs so as to not exacerbate any tachyarrhythmias with rib raising, thoracic myofascial release, and a pectoralis lift. The investigator will then proceed with opening the thoracic inlet, cervical myofascial release, suboccipital release, and then end by checking for and treating Chapman's points. The physician will submit their osteopathic evaluation and fill out a form in order to determine if certain arrhythmias have an associated trigger point.

Group II: Light Touch TreatmentPlacebo Group1 Intervention

Group B will receive a light touch treatment, based on previous research done studying heart rate variability and OMM, where sham treatment was utilized. The protocol consisted of contacting the right ankle, left knee, right hip, diaphragm, right shoulder, neck, and cranium for precisely two minutes each, with the goal of preventing placebo autonomic nervous system stimulation. The protocol is 25 minutes long, with 10 minutes for the evaluation and 15 minutes for treatment.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Osteopathic Manipulative Treatment

2008

Completed Phase 4

~2570

Do I qualify?Apply below to find out